AF
Publicaties op Oncologisch.com
Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to Eerstelijns Pembro...
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIE...
Rucaparib versus standaardchemotherapie bij recidief ovariumcarcinoom met BRCA-deletie: ARIEL4 fase III